Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist.
Newcastle disease virus (NDV) edits its P gene by inserting one or two G residues at the conserved editing site (UUUUUCCC, genome sense) and transcribes the P mRNA (unedited), the V mRNA (with a +1 frameshift), and the W mRNA (with a +2 frameshift). All three proteins are amino coterminal but vary at their carboxyl terminus in length and amino acid composition. Little is known about the role of the V and W proteins in NDV replication and pathogenesis. We have constructed and recovered two recombinant viruses in which the expression of the V or both the V and W proteins has been abolished. Compared to the parental virus, the mutant viruses showed impaired growth in cell cultures, except in Vero cells. However, transient expression of the carboxyl-terminal portion of the V protein enhanced the growth of the mutant viruses. In embryonated chicken eggs, the parental virus grew to high titers in embryos of different gestational ages, whereas the mutant viruses showed an age-dependent phenomenon, growing to lower titer in more-developed embryos. An interferon (IFN) sensitivity assay showed that the parental virus was more resistant to the antiviral effect of IFN than the mutant viruses. Moreover, infection with the parental virus resulted in STAT1 protein degradation, but not with the mutant viruses. These findings indicate that the V protein of NDV possesses the ability to inhibit alpha IFN and that the IFN inhibitory function lies in the carboxyl-terminal domain. Pathogenicity studies showed that the V protein of NDV significantly contributes to the virus virulence.
Huang
Zhuhui
Z
Virginia-Maryland Regional College of Veterinary Medicine, University of Maryland, College Park, Maryland 20742, USA.
Krishnamurthy
Sateesh
S
Panda
Aruna
A
Samal
Siba K
SK
D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D002642:Chick Embryo; D017931:DNA Primers; D018076:DNA, Complementary; D005816:Genetic Complementation Test; D016898:Interferon-alpha / Q000037:antagonists & inhibitors*; D009154:Mutation; D009522:Newcastle disease virus / Q000254:growth & development / Q000472:pathogenicity / Q000502:physiology*; D017393:RNA Editing; D014764:Viral Proteins / Q000502:physiology*
C070065:36 kDa V protein, Newcastle disease virus; D017931:DNA Primers; D018076:DNA, Complementary; D016898:Interferon-alpha; D014764:Viral Proteins